Chang-Hee Suh Selected Research

Aspirin (Acetylsalicylic Acid)

2/2007	Significant association of FcepsilonRIalpha promoter polymorphisms with aspirin-intolerant chronic urticaria.
6/2006	Circulating autoantibodies in patients with aspirin-intolerant asthma: an epiphenomenon related to airway inflammation.
1/2006	Lack of an association between a newly identified promoter polymorphism (-1702G > A) of the leukotriene C4 synthase gene and aspirin-intolerant asthma in a Korean population.
12/2005	Leukotriene-related gene polymorphisms in patients with aspirin-intolerant urticaria and aspirin-intolerant asthma: differing contributions of ALOX5 polymorphism in Korean population.
9/2005	Lack of association of glutathione S-transferase P1 Ile105Val polymorphism with aspirin-intolerant asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chang-Hee Suh Research Topics

Disease

43	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2024 - 02/2003
35	Rheumatoid Arthritis 04/2024 - 01/2007
17	Adult-Onset Still's Disease 05/2022 - 11/2003
16	Inflammation (Inflammations) 11/2021 - 06/2004
8	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 02/2003
8	Asthma (Bronchial Asthma) 12/2006 - 06/2004
7	Ankylosing Spondylitis 05/2022 - 08/2012
6	Infections 04/2024 - 06/2006
6	Osteoporosis 01/2024 - 11/2017
5	Necrosis 07/2023 - 05/2015
5	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2023 - 01/2017
5	Thrombocytopenia (Thrombopenia) 02/2022 - 01/2015
5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 12/2021 - 07/2012
4	Proteinuria 07/2023 - 05/2018
4	Rheumatic Diseases (Rheumatism) 05/2023 - 01/2018
4	Nephritis 01/2021 - 09/2007
3	Lupus Nephritis 04/2022 - 05/2018
3	Arthritis (Polyarthritis) 01/2021 - 08/2014
3	Serositis 01/2019 - 01/2010
2	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2024 - 03/2023
2	COVID-19 08/2023 - 05/2022
2	Hypersensitivity (Allergy) 08/2023 - 02/2007
2	Neoplasms (Cancer) 07/2023 - 07/2006
2	Psoriatic Arthritis 04/2023 - 01/2021
2	Osteoporotic Fractures 05/2022 - 12/2018
2	Fever (Fevers) 02/2022 - 12/2017
2	Vasculitis (Vasculitides) 12/2021 - 12/2018
2	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 07/2020 - 01/2012
2	Tuberculosis (Tuberculoses) 06/2020 - 01/2016
2	Immune System Diseases (Immune Disorders) 01/2020 - 10/2019
2	Alopecia (Baldness) 12/2019 - 08/2014
2	Skin Manifestations 11/2019 - 01/2017
2	Atherosclerosis 08/2019 - 01/2019
2	Hypertriglyceridemia 11/2018 - 01/2015
2	Exanthema (Rash) 01/2017 - 08/2016
2	Leukopenia 01/2015 - 08/2008
2	Joint Diseases (Joint Disease) 09/2012 - 07/2006
2	Disease Susceptibility (Diathesis) 11/2010 - 10/2009
2	Urticaria (Hives) 12/2005 - 06/2005
1	Vitamin D Deficiency 01/2024
1	Human Influenza (Influenza) 08/2023
1	Hypercholesterolemia 07/2023

Drug/Important Bio-Agent (IBA)

14	Biosimilar PharmaceuticalsIBA 04/2023 - 01/2017
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2007
12	Rituximab (Mabthera)FDA Link 04/2022 - 01/2012
10	C-Reactive ProteinIBA 05/2022 - 06/2006
9	GlucocorticoidsIBA 01/2024 - 11/2017
8	Antirheumatic Agents (DMARD)IBA 04/2024 - 07/2006
8	CT-P10IBA 12/2020 - 01/2017
7	CytokinesIBA 07/2023 - 11/2003
6	AutoantibodiesIBA 07/2023 - 06/2006
6	AntibodiesIBA 02/2022 - 09/2004
6	Interleukin-6 (Interleukin 6)IBA 08/2021 - 06/2006
5	Tumor Necrosis Factor InhibitorsIBA 04/2023 - 01/2016
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2021 - 08/2012
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2007 - 09/2005
4	Messenger RNA (mRNA)IBA 07/2023 - 07/2021
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2014
4	Peptides (Polypeptides)IBA 11/2021 - 02/2003
4	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2021 - 01/2020
4	AlbuminsIBA 07/2021 - 10/2006
4	Complement System Proteins (Complement)IBA 01/2021 - 08/2008
4	Immunoglobulin E (IgE)IBA 02/2007 - 07/2003
4	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 12/2006 - 06/2004
3	Immunoglobulins (Immunoglobulin)IBA 04/2023 - 01/2021
3	Infliximab (Remicade)FDA Link 10/2021 - 06/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 07/2006
3	LigandsIBA 01/2020 - 01/2010
3	anti-dsDNA autoantibodyIBA 12/2019 - 08/2008
3	HLA Antigens (Human Leukocyte Antigens)IBA 10/2019 - 01/2018
3	Interleukin-10 (Interleukin 10)IBA 03/2008 - 06/2006
3	EnzymesIBA 01/2006 - 09/2004
2	Vitamin D FDA LinkGeneric 01/2024 - 09/2011
2	VaccinesIBA 08/2023 - 05/2022
2	Janus Kinase InhibitorsIBA 05/2023 - 03/2023
2	Etanercept (Enbrel)FDA Link 04/2023 - 01/2019
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022 - 06/2009
2	AutoantigensIBA 12/2021 - 09/2004
2	Salivary Proteins and PeptidesIBA 11/2021 - 01/2021
2	CT-P13IBA 10/2021 - 06/2020
2	tocilizumab (atlizumab)FDA Link 08/2021 - 12/2018
2	Antinuclear AntibodiesIBA 07/2021 - 06/2006
2	InterferonsIBA 07/2021 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2014
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 12/2018
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019 - 05/2018
2	Protein SIBA 01/2019 - 01/2010
2	growth arrest-specific protein 6IBA 06/2014 - 01/2013
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2012 - 01/2006
2	Methacholine Chloride (Methacholine)FDA Link 10/2006 - 06/2006
2	Immunoglobulin G (IgG)IBA 06/2006 - 09/2004
1	Zoledronic Acid (Zometa)FDA Link 01/2024
1	Diphosphonates (Bisphosphonates)IBA 01/2024
1	belimumabIBA 12/2023
1	Influenza Vaccines (Influenza Vaccine)FDA Link 08/2023
1	Rosuvastatin Calcium (Crestor)FDA Link 07/2023
1	Interleukin-17 (Interleukin 17)IBA 07/2023

Therapy/Procedure

12	Therapeutics 03/2023 - 05/2012
2	Biological Therapy 08/2021 - 08/2017
2	Drug Therapy (Chemotherapy) 09/2012 - 07/2006